Publications by authors named "Elise Munsey"
Front Cardiovasc Med
August 2024
Article Synopsis
- - Mavacamten is a groundbreaking drug approved for treating obstructive hypertrophic cardiomyopathy (oHCM), showing notable improvements in heart function and symptoms in 50 real-world patients.
- - Patients experienced significant reductions in heart wall thickness and related complications, with only a small number needing to temporarily stop treatment due to minor decreases in heart function.
- - The approach taken at the care center allowed for the rapid introduction and monitoring of this new therapy, reinforcing mavacamten's safety and effectiveness outside of traditional clinical trial settings.
